In the present study, we demonstrated that FXR promotes the migration, invasion, and angiogenic ability of NSCLC cells in vitro, and increases NSCLC metastasis in mouse models in vivo. This evidence concerns the gene NR1H4 and non-small cell lung carcinoma.